Article Details
Retrieved on: 2024-03-19 17:32:10
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca has reported treatment benefits in findings from the DUO-E clinical trial of Imfinzi (durvalumab) plus Lynparza (olaparib).
Article found on: www.clinicaltrialsarena.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here